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routine staging of patients with a wide variety of primary
malignancies. Although it is a sensitive imaging modality, it
is relatively nonspecific, and there are many potential causes
of increased isotope uptake that can mimic metastatic
disease. The procedure is performed with technetium
99m-labeled diphosphonates. The uptake of these radio-
pharmaceuticals depicts osteoblastic activity and regional
blood flow to bone. By 2-6 hours after injection, about 50%
of the injected dose is in the skeletal system and, therefore,
delayed static imaging usually is performed at this time by
using a gamma camera and a low-energy, high-resolution
collimator [1,2]. In this review, the following lesions and
patterns of uptake will be discussed - benign bone lesions,
degenerative disease, trauma, infection, superscans, soft-
tissue uptake and artifacts.
Benign Bone Lesions
Many benign bone lesions demonstrate increased uptake
of a radiopharmaceutical on bone scintigraphy; these are
listed below.
 Fibrous dysplasia. Fibrous dysplasia is a relatively
common benign skeletal disorder in which the normal
medullary space is replaced by fibro-osseous tissue. It can
affect just a single bone (monostotic) or multiple bones
(polyostotic). Typically, fibrous dysplasia lesions exhibit
markedly increased uptake of a radiopharmaceutical,* Address for correspondence: Dr Deirdre E. Moran, Department of Diag-
nostic Radiology, StVincent’sUniversityHospital, ElmPark,Dublin 4, Ireland.
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multiple unilateral limb lesions (Figure 1, A and B). Bone
scintigraphy is particularly useful in demonstrating the
extent of disease in patients with polyostotic fibrous
dysplasia [3].
 Paget disease. Paget disease of bone is a metabolic
disorder in which there is excessive and abnormal
remodelling of bone. Typically, there are 3 phases: the
lytic phase, the mixed phase, and the blastic phase. Bone
scintigraphy typically demonstrates marked increased
uptake of a radiopharmaceutical in all phases of Paget
disease (Figure 2, A and B) [4]. In vertebrae, there is
involvement of the whole bone (body and posterior
elements), and, in long bones, the increased uptake
extends from one end of the bone for a variable length
throughout the bone.
 Enchondroma. Enchondromas are common benign
cartilaginous neoplasms that occur in the medullary
cavity of bone. Mild-to-moderate uptake of a radiophar-
maceutical is usually demonstrated on bone scintigraphy
(Figure 3, A-C) [5].
 Bone island. An enostosis or bone island represents
a focus of mature compact (cortical) bone within the
cancellous bone. A distinguishing feature of bone islands
is that they usually are photopenic on skeletal scintigraphy.
However, giant bone islands (>2 cm) can show increased
uptake of a radiopharmaceutical (Figure 4, A and B) [6,7].
 Hemangioma. Vertebral hemangiomas,when smaller than
3 cm in size, generally show normal uptake of a radio-
pharmaceutical. However, larger lesions may demonstrate
either increased or decreased uptake (Figure 5) [8].
 Osteitis condensans ilii. Osteitis condensans ilii is
benign sclerosis of the iliac side of the sacroiliac (SI)ll rights reserved.
Figure 1. (A) A 48-year-old man. An anterior whole-body bone scintigram, demonstrating increased uptake of a radiopharmaceutical in the right side of the
skull base, right humerus, left femur, and left tibia (arrows). (B) A 48-year-old man. Anterioposterior (AP) radiographs of the left femur, left tibia, and right
humerus demonstrate lucent, slightly expansile lesions, with internal ‘‘ground-glass’’ matrix in the proximal femoral shaft, mid shaft of the humerus, and distal
shaft of the tibia typical of fibrous dysplasia (arrowheads).
Figure 2. (A)A51-year-oldwoman.Anterior (left) and posterior (right)whole-bodybone scintigrams demonstrate increased uptake of a radiopharmaceutical in the
sacrum, particularly on the left side (arrows). (B) A 51-year-old woman. T1-weighted magnetic resonance image of the sacrum, demonstrating marked cortical
thickening within the left sacral ala (arrow), with focally increased intramedullary fat (arrowhead) consistent with the diagnosis of Paget disease of bone.
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Figure 3. (A) A 49-year-old woman with a history of breast cancer. Anterior bone scintigram, showing increased radiopharmaceutical uptake in the proximal
right humeral shaft (arrow). (B) A 49-year-old woman with a history of breast cancer. Anterioposterior radiograph of the right humerus, demonstrating calcified
chondroid matrix within the proximal right humeral shaft (arrow), consistent with an enchondroma. (C) A 49-year-old woman with a history of breast cancer.
Sagittal T2* sequence from an magnetic resonance image of the right shoulder, showing an enchondroma in the neck of the right humerus. There is
‘‘blooming’’ of the internal calcification on a background of high signal, typical of chondroid matrix.
Figure 4. (A) A 59-year-old woman. Anterior bone scintigram, showing minimal increased uptake in the distal shaft of the left femur (arrow). (B) A 59-year-old
woman. Lateral radiograph of the left knee, demonstrating a giant bone island in the distal left femoral shaft (arrow), with the long axis of the sclerotic lesion
along the long axis of the femur, as is usually the case with bone islands. The subtle increase in radiopharmaceutical uptake on scintigraphy is explained by the
increased volume of dense bone, without any increase in osteoblastic activity.
Figure 5. A 71-year-old woman with a history of breast cancer. Anterior bone scintigram (left), demonstrating significant increased uptake in the left side of the
body of L1 suspicious for a metastasis. Computed tomography (CT) was suggestive of a vertebral hemangioma, with vertical spicules of bone in the lesion.
However, in view of the increased uptake on bone scintigraphy, CT-guided biopsy (right) was performed, which confirmed that the lesion was a hemangioma.
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Figure 6. (A) A 55-year-old woman with a history of breast cancer. Posterior bone scintigram, demonstrating increased uptake of a radiopharmaceutical in the
right ilium adjacent to the right sacroiliac joint (arrow). (B) A 55-year-old woman with a history of breast cancer. Anterioposterior radiograph of the pelvis,
demonstrating a typical triangular area of sclerosis on the iliac side of the right sacroiliac joint, with preservation of the right sacroiliac joint space, consistent
with osteitis condensans ilii.
Figure 7. (A) A 70-year-old woman. Anterior (left) and posterior (right) planar scintigrams of the pelvis, demonstrating increased uptake of a radiopharma-
ceutical in the weight-bearing (superior) portion of the left acetabulum (arrows), consistent with degenerative disease. (B) A 58-year-old woman with metastatic
breast cancer. By contrast, in this patient with metastatic involvement of the left acetabulum, anterior (left) and posterior (right) planar scintigrams of the pelvis,
demonstrating increased uptake of a radiopharmaceutical throughout the left acetabulum (arrows), consistent with malignant disease. (C) A 58-year-old woman
with metastatic breast cancer. Anterioposterior radiograph of the left acetabulum in the same patient as (B), demonstrating a large lytic lesion (arrow),
consistent with a bony metastasis.
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Figure 8. A 63-year-old man. Anterior (left) and posterior (right) planar scintigrams of the cervical spine, demonstrating a mid cervical lateral focus of
increased uptake (arrows). Lateral uptake of a radiopharmaceutical in the cervical spine is invariably benign.
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rarely unilateral. It usually is found in young multiparous
women. Increased uptake of a radiopharmaceutical on
the iliac side of affected Si joints is demonstrated (Figure
6, A and B) [9].
 Eosinophilic granuloma. Eosinophilic granuloma is
a form of Langerhans cell histiocytosis and usually is
seen in pediatric patients. It has many radiographic
appearances and may be a well-defined lytic lesion
without a rim of sclerosis, or it may be ill defined and
permeative in appearance. The scintigraphic findings
vary from either a photopenic area or a focal area of
increased uptake [5].Figure 9. (A) A 60-year-old woman with breast cancer. Anterior bone scintigram
teristic linear distribution of the anterior 5th-8th ribs on the left secondary to rib f
due to insufficiency fractures. (B) A 67-year-old woman. The characteristic ‘‘Ho
Multiple other fractures are present within the ribs, pubic rami, and mid thoraci Melorheostosis. Melorheostosis is a rare, benign, scle-
rosing bone dysplasia that demonstrates dense bone
formation, typically along the cortex of tubular bones. It
has a ‘‘dripping candle wax’’ pattern on plain film. Bone
scintigraphy typically shows moderately increased
uptake of a radiopharmaceutical [10].
 Osteoid osteoma. This is a benign tumour that consists of
an osteoblastic mass or nidus surrounded by a zone of
reactive sclerosis. Characteristically, there is increased
uptake on bone scan, and the double-density sign, which
consists of a small focus of increased activity (nidus)
surrounded by a larger area of less-intense activity (reac-
tive sclerosis), is helpful in diagnosis [11]., showing markedly increased uptake of a radiopharmaceutical in a charac-
ractures. The increased uptake in the left sacrum and pubic rami bilaterally is
nda’’ sign is demonstrated on the posterior planar scintigram (right, arrow).
c spine in this patient with osteoporosis.
Figure 10. (A) A 28-year-old woman. Anterior bone scintigram, demonstrating increased radiopharmaceutical uptake in the right humeral head and supra-
acetabular region of the right iliac bone (arrows). (B) A 28-year-old woman. Coronal short T1 inversion recovery sequence from an magnetic resonance
image (MRI) of the pelvis, demonstrating high signal within the superior aspect of the right acetabulum (arrow), which corresponds with the scintigraphic
abnormality. The patient had biopsy-proven tuberculous osteomyelitis. (C) A 28-year-old woman with TB osteomyelitis. Axial T1-weighted MRI of the right
shoulder with fat saturation and after gadolinium, demonstrating avid enhancement of the lesion within the proximal right humerus (arrow) and enhancing
axillary adenopathy (arrowhead).
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lage-covered bony projection on the external surface of
bone. The scintigraphic appearances are variable and are
directly correlated with the degree of enchondral bone
formation. Generally, there is more prominent radiophar-
maceutical uptake in osteochondromas in younger patients
and osteochondromas without increased radiopharma-
ceutical uptake are more frequent in older patients [12].Degenerative Disease
Degenerative diseasemanifests as areas of increased uptake
on radionuclide bone scans. It can be distinguished from
metastatic disease by its characteristic locations (Figure 7,
A-C). The medial compartment of the knee, the hand (espe-
cially the base of the first metacarpal), the wrist, the shoulders,
and the feet are classic locations for osteoarthritis [2]. Both
Figure 11. (A) A 49-year-old female patient with hyperparathyroidism; whole-body Technetium 99m scintigraphy, demonstrating a ‘‘superscan,’’ with
uniformly increased activity throughout the skeleton. (B) A 49-year-old female patient with hyperparathyroidism; sestamibi scan of the parathyroid glands,
demonstrating increased uptake projected over the left lobe of the thyroid gland, consistent with parathyroid adenoma (arrow). (C) A 51-year-old woman with
metastatic breast cancer. Whole-body 99mTc scintigraphy in this patient with breast cancer, demonstrating a ‘‘superscan,’’ with nonuniform increased activity
throughout the skeleton secondary to widespread bony metastases.
286 D. E. Moran et al. / Canadian Association of Radiologists Journal 63 (2012) 280e288sides of the joint can be involved in arthritis, but this is unusual
inmalignant disease. Degenerative changes in the spine can be
more challenging because bothmetastasis and arthritic change
can occur in the same location; single photon emission
computed tomography can help to localize the uptake in the
facet joints, which can avoid the need for further imaging in
a patient with degenerative disease. However, lateral uptake of
a radiopharmaceutical in the cervical spine is almost invariably
benign (Figure 8) [13].
Trauma
It is possible to distinguish metastatic disease from trauma
by analysing the pattern of distribution of uptake. Multifocal
rib fractures (Figure 9A) have a characteristic linear distri-
bution. The characteristic appearance of sacral insufficiency
fractures (Figure 9B) is fracture lines that run vertically
through both sacral ala, medial to the SI joints, and a trans-
verse fracture at the level of the SI joints. The fractures often
have a characteristic ‘‘butterfly’’ or ‘‘Honda sign’’appearance. Other typical sites for insufficiency fractures
include the pubic bones, pubic rami, and supra-acetabular
region of the iliac bone.
Infection
Three-phase bone scanning is the radionuclide procedure
of choice for diagnosing osteomyelitis in bone, but it can be
encountered on static images when staging malignant
disease. On classic static delayed images, osteomyelitis
appears as an area of focally increased radiopharmaceutical
uptake. Multifocal osteomyelitis can simulate metastatic
disease (Figure 10, A-C) [14].Diffuse Symmetrical Increased Uptake in Bone
(‘‘Superscan’’)
A superscan is defined as a bone scan that demonstrates
markedly increased skeletal radiopharmaceutical uptake
Figure 12. (A) A 50-year-old woman with a horseshoe kidney. The orientation of the kidney on this whole-body scintigram is typical of that found in
a horseshoe kidney, with the lower poles pointing medially (arrow). (B) A 50-year-old woman with a horseshoe kidney; subsequent T2-weighted axial magnetic
resonance image (MRI) of the lumbar spine confirmed the presence of a horseshoe kidney. (C) A 39-year-old woman with bladder extrophy, pubic diastasis,
and ureterosigmoidostomy. Excretion of a radiopharmaceutical via the ureterosigmoidostomy is noted in this patient with a history of bladder extrophy (arrow).
(D) A 90-year-old man; whole-body bone scintigraphy, with increased uptake of a radiopharmaceutical within the left ventricle (arrows); the patient had
a history of myocardial infarction. (E) A 74-year-old man with a history of breast cancer; posterior bone scintigram, demonstrating increased uptake in the
ischial tuberosities bilaterally, greater on the left (arrow) than the right (arrowhead). (F) A 74-year-old man with a history of breast cancer; coronal short T1
inversion recovery (left) and T1-weighted (right) sequences from an MRI of the pelvis, demonstrating a chronic avulsion of the right hamstring tendon with
avulsion of a bony fragment (arrowheads) and high signal within the left hamstring tendon, consistent with tendinopathy (arrows).
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a superscan include metabolic diseases, such as hyperpara-
thyroidism (Figure 11, A and B), hyperthyroidism, renal
osteodystrophy, and osteomalacia, or widespread bone
lesions, such as widespread Paget disease. Nonmalignant
superscans typically demonstrate a uniform pattern of
increased uptake, whereas superscans in patients with
widespread metastases demonstrate a nonuniform pattern of
uptake (Figure 11C).
Soft-Tissue Uptake
Physiologic uptake can be demonstrated within the
kidney, bowel, and breast. A congenital variant can bedemonstrated incidentally, such as in the case of a horseshoe
kidney (Figure 12, A and B). If the patient has had surgical
diversion of the urinary tract (Figure 12C), then a radio-
pharmaceutical is excreted through the bowel conduit.
Myocardial uptake can be seen in patients with previous
myocardial infarction (Figure 12D), long-standing conges-
tive heart failure, pericarditis, amyloidosis, and unstable
angina, and after resuscitation or cardioversion. Inflamma-
tion within soft-tissue structures can cause increased uptake
on bone scintigraphy, and soft-tissue uptake can be seen in
patients with tendinopathy (Figure 12, E and F), bursitis,
abscess, and crystalline arthropathy, and after radiation.
Heterotopic ossification causes increased uptake due to the
presence of extraskeletal osteoblasts.
Figure 13. (A) A 72-year-old woman with metastatic breast cancer and portacath device in situ. Anterior bone scintigram, demonstrating artifactual radio-
pharmaceutical uptake in relation to the right-sided portacath (arrows); the patient also has metastatic disease that involves the sternum. (B) A 41-year-old
woman with newly diagnosed breast cancer. Whole-body bone scintigraphy, demonstrating residual radiopharmaceutical in the left breast from a sentinel node
procedure performed 1 day before the bone scan (arrow).
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Medical devices, such as central venous access catheters
(Figure 13A), can demonstrate increased uptake of a radio-
pharmaceutical. Patients who have had a previous radionu-
clide procedure, such as sentinel node injection (Figure 13B),
can have residual radiopharmaceutical, which is detected on
subsequent bone scintigraphy.
Conclusion
There are many causes of increased radiopharmaceutical
uptake on bone scintigraphy. Knowledge of both the benign
and malignant causes of a ‘‘positive’’ bone scan is integral to
the interpretation of bone scintigraphy, which allows the
recommendation of an appropriate imaging modality for
further evaluation and optimum characterization of these
lesions where necessary. In turn, radiologists who do not
primarily report nuclear medicine examinations should be
familiar with the wide range of benign bone and soft-tissue
lesions that can result in increased radiopharmaceutical
uptake and which may mimic metastatic disease; in some
cases, this may prevent the patient from having an unnec-
essary invasive procedure or biopsy.
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